Brain Aneurysm Patent Case Nearly Set For Trial

Law360, New York (August 29, 2007, 12:00 AM EDT) -- A judge in the patent infringement lawsuit between the University of California and medical device maker Micro Therapeutics Inc. has set the stage for a trial after rejecting summary judgment motions from both sides.

The university, which had accused MTI and its subsidiary Dendron GmbH of infringing 12 patents related to the treatment of brain aneurysms, had moved for summary judgment on infringement grounds. MTI had moved for summary judgment on invalidity grounds.

Over the last few months, Judge James Ware of the U.S. District Court...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.